Private hospital operator Ramsay Health Care (ASX:RHC) warned that impairments and impairment fees at some of its European hospitals would weaken their underlying effects for 2023-24 from a year earlier.
However, the profit from the sale of your Sime Darby business will especially increase the legal profit.
Ramsay expects profits from ongoing operations of between $265 million and $270 million for the year ending in June. This is lower than the A$278. 2 million profit reported for the 2022-23 year.
The statutory profit is expected to be between $884 million and $889 million, the $618 million gain from the sale of the Ramsay Sime Darby business.
In Monday’s regulatory filing, Ramsay reported non-cash impairments and accelerated impairments of $24. 5 million in the price of underperforming assets in Ramsay Health and the UK region.
Ramsay, however, said he is reaping benefits from increased hard work and productivity, while capital spending in 2023-24 declines than anticipated, at around $740 million, due to unusually low spending in Australia.
Ramsay is scheduled to verify its 2023-24 effects on Aug. 30.
Get updates delivered straight to your inbox.
Terms of use | Privacy Policy | Contact | Announce
Overall increases for Deep Leads resources: quality, tonnage and target area ABx Group has reported a 30% increase in its mineral resource estimate (MRE) at the rare Deep Leads ion adsorption clay (IAC) earth deposit Leads in northern Tasmania. The accumulation at MRE comes from 36 assayed extension wells, representing significant northward extension to the existing Deep Leads prospect.
Lake Resources (LKE. ASX) – LKE has signed two non-binding memorandums of understanding in the 10-day area. Ford Company (Ford) signed a memorandum of understanding for around 25,000 t/year and last week, Hanwa, a Japanese raw materials trader, signed a memorandum of understanding for up to 25,000 t/year. Subject to execution, this is a feat as Ford and Hanwa are set to engage in longer-term strategic partnerships with LKE. Commercial negotiations are still ongoing but should, if Ford and Hanwa inject new capital into LKE, further de-risk the project financing and thus ensure that LKE and Kachi are fully funded.
Two recent gravity studies have particularly exceeded expectations and revealed prospects for extension of the existing MRE at Throssell Lake, as well as a significant expansion opportunity at Yeo Lake. This reinforces the prospect of a multi-decade SOP Tier 1 production center around Lake Throssell.
TMG is currently completing work for the PFS planned in early 2023, adding the start of drilling in the third quarter of 2022, evaporation testing and authorization activities. The effects of those systems will affect the PFS and any long-term resource updates.
The SOP reference values have increased to approximately $940/t due to recent geopolitical events. The October 2021 scoping study assumed an SOP value of $550/t and contained a sensitivity study showing that every 10% increased value effects in a $144 million NPV increase in the $364 million task NPV. The increase of approximately 70% compared to the scoping study implies a NPV allocation of approximately $1. 4 billion.
Despite the fall in oil and fuel prices, which fell by 5. 4% and 19. 7% respectively in August, Calima managed to show an improvement in its main indicators.
WT Financial Group Limited (WTL) is a rapidly growing diversified monetary company, founded in 2010 and indexed on the Australian Stock Exchange (ASX) in 2015. Its recommendations and product offerings are provided primarily through an advisory organization independent monetary advisors who act as legal advisors. representatives. WTL in relation to its broker organization activities Wealth Today Pty Ltd (Wealth Today) and Sentry Group Pty Ltd (Sentry Group). It has approximately 275 advisors in over two hundred money advice companies across Australia. It also operates a direct-to-consumer operation under its Spring Financial Group brand.
In May 2021, Corporate Connect analyst Marc Sinatra published a full study report on ASX-listed biotech Immutep Ltd (ASX: IMM). He was so inspired by IMM that Corporate Connect found it imperative to publish a follow-up report that valued the company, as the market did not see the great prospects of eftilagimod alfa (efti).
This follow-up report was released today. Using comparables, after adding a monetary rebate to its EV estimate and dividing by the total number of percentages issued, Corporate Connect now puts the fair price of a percentage of Immutep at AU$2. 20.